Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04130256 · ClinicalTrials.gov registry record · NA
Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple Sclerosis
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT04130256: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04130256 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04130256, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
People with multiple sclerosis (MS) have variable adherence to MS medications, making the full efficacy of disease modifying therapies unrealized and the assessment of true treatment failures challenging. Whereas some patients forget to take medications due to active lifestyles, others may have cognitive impairments that prevent them from organizing and planning their regular dosing schedules. An electronic pill cap ("Pillsy") has been developed to record pill taking, timing, and set reminders through a mobile app. Data on adherence can be captured and analyzed remotely for health care provider review.
Interventions
- DEVICE Electronic Pill Bottle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2021-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04130256
The ClinicalTrials.gov registry entry for NCT04130256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electronic Pill Bottle is the first listed.
NCT04130256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04130256 about?
NCT04130256 is a clinical study titled "Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple Sclerosis". People with multiple sclerosis (MS) have variable adherence to MS medications, making the full efficacy of disease modifying therapies unrealized and the assessment of true treatment failures challenging. Whereas some patients forget to take medications due to active lifestyles, others may have cogn...
What is the current status of trial NCT04130256?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2019-11-15. Estimated completion is 2021-01-26.
What interventions are being tested in trial NCT04130256?
The interventions under investigation include: Electronic Pill Bottle (DEVICE).
Who is sponsoring clinical trial NCT04130256?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.